Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice.

MLA

Qing, Jing, et al. “Antibody-Based Targeting of FGFR3 in Bladder Carcinoma and t(4;14)-Positive Multiple Myeloma in Mice.” The Journal of Clinical Investigation, vol. 119, no. 5, May 2009, pp. 1216–29. EBSCOhost, https://doi.org/10.1172/JCI38017.

APA

Qing, J., Du, X., Chen, Y., Chan, P., Li, H., Wu, P., Marsters, S., Stawicki, S., Tien, J., Totpal, K., Ross, S., Stinson, S., Dornan, D., French, D., Wang, Q.-R., Stephan, J.-P., Wu, Y., Wiesmann, C., & Ashkenazi, A. (2009). Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice. The Journal of Clinical Investigation, 119(5), 1216–1229. https://doi.org/10.1172/JCI38017

Chicago

Qing, Jing, Xiangnan Du, Yongmei Chen, Pamela Chan, Hao Li, Ping Wu, Scot Marsters, et al. 2009. “Antibody-Based Targeting of FGFR3 in Bladder Carcinoma and t(4;14)-Positive Multiple Myeloma in Mice.” The Journal of Clinical Investigation 119 (5): 1216–29. doi:10.1172/JCI38017.